Eximo
Boston, US · 3 known investors
Medical device company with a single-use hybrid catheter for precise material removal; acquired by AngioDynamics in 2019.
Founders & leadership
EW
Evan WittNamed on SEC filing
JT
Josh TayloeNamed on SEC filing
Investors · 3
Reported raises · per SEC filings
Form D private placements$780K disclosed across 1 round · 2012
▶$780KraisedFeb 2012 · 7 investors · Business ServicesRule 506(b)
▶$780KraisedFeb 2012 · 7 investors · Business Services
Rule 506(b)Officers, directors & promoters on the filing
- Evan WittExecutive Officer, Director
- Josh TayloeExecutive Officer
- Offering amount
- $780K
- Amount sold
- $780K
- Minimum investment
- $25K
- First sale
- Jan 2012
- Incorporated
- Limited Liability Company, Massachusetts
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Eximo do?
- Medical device company with a single-use hybrid catheter for precise material removal; acquired by AngioDynamics in 2019.
- Who are Eximo's investors?
- Eximo's investors include Accelmed Partners, Peregrine Ventures, Tal Ventures.
- How much funding has Eximo raised?
- Eximo has disclosed $780K raised across 1 round.
- Where is Eximo headquartered?
- Eximo is headquartered in Boston, US.